Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

Salvatore L. Ruggiero(Long Island Jewish Medical Center), Bhoomi Mehrotra(Long Island Jewish Medical Center), Tracey J. Rosenberg(Long Island Jewish Medical Center), Stephen L. Engroff(University of Maryland Medical System)

Journal of Oral and Maxillofacial Surgery

April 23, 2004

10.1016/j.joms.2004.02.004

Cited by 2,054

Abstract

Related Papers

Bisphosphonates: mechanisms of action.

Gideon A. Rodan, H. Fleisch|Journal of Clinical Investigation|1996|924

Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

Tasuku Mashiba, Tôru Hirano, Charles H. Turner et al.|Journal of Bone and Mineral Research|2000|696

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

James R. Berenson, Alan Lichtenstein, Lisa A. Porter et al.|Journal of Clinical Oncology|1998|653

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

G. N. Hortobagyi, Richard L. Theriault, A. Lipton et al.|Journal of Clinical Oncology|1998|632

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

Richard L. Theriault, Allan Lipton, Gabriel N. Hortobágyi et al.|Journal of Clinical Oncology|1999|606